
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About


Adapthealth Corp (AHCO)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: AHCO (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $12.88
1 Year Target Price $12.88
5 | Strong Buy |
1 | Buy |
2 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -74.24% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.29B USD | Price to earnings Ratio 16.54 | 1Y Target Price 12.88 |
Price to earnings Ratio 16.54 | 1Y Target Price 12.88 | ||
Volume (30-day avg) 8 | Beta 1.64 | 52 Weeks Range 7.11 - 11.90 | Updated Date 07/1/2025 |
52 Weeks Range 7.11 - 11.90 | Updated Date 07/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.57 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.63% | Operating Margin (TTM) 3.63% |
Management Effectiveness
Return on Assets (TTM) 3.82% | Return on Equity (TTM) 5.9% |
Valuation
Trailing PE 16.54 | Forward PE 9.53 | Enterprise Value 3323528185 | Price to Sales(TTM) 0.4 |
Enterprise Value 3323528185 | Price to Sales(TTM) 0.4 | ||
Enterprise Value to Revenue 1.02 | Enterprise Value to EBITDA 5.41 | Shares Outstanding 134948000 | Shares Floating 89408354 |
Shares Outstanding 134948000 | Shares Floating 89408354 | ||
Percent Insiders 8.03 | Percent Institutions 102.26 |
Analyst Ratings
Rating 2 | Target Price 12.88 | Buy 1 | Strong Buy 5 |
Buy 1 | Strong Buy 5 | ||
Hold 2 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Adapthealth Corp

Company Overview
History and Background
AdaptHealth Corp. (formerly known as DFB Healthcare Acquisitions Corp.) was founded in 2012. It has grown significantly through acquisitions, consolidating fragmented durable medical equipment (DME) and home healthcare services. The company focuses on providing a range of medical equipment and supplies, focusing on respiratory, mobility, and sleep therapy solutions.
Core Business Areas
- Respiratory Equipment: Provides oxygen therapy, ventilation equipment, and related supplies to patients with respiratory conditions.
- Sleep Therapy Equipment: Offers CPAP and BiPAP machines, masks, and accessories for patients with sleep apnea.
- Mobility Equipment: Supplies wheelchairs, mobility scooters, walkers, and other assistive devices for individuals with mobility impairments.
- Home Medical Equipment (HME): A broad category that includes various types of durable medical equipment used in the home setting, addressing diverse patient needs beyond respiratory, sleep and mobility.
Leadership and Structure
The leadership team includes Stephen Griggs (CEO) and Josh Loyd (CFO). The organizational structure is built around regional operations and centralized support functions like billing and IT.
Top Products and Market Share
Key Offerings
- CPAP and BiPAP Machines: Provides CPAP machines and related supplies for sleep apnea treatment. Market share data is difficult to pinpoint exactly, but Adapthealth is a major player in the market. Competitors include ResMed, Philips (Recalled devices have impacted them), and Lincare.
- Oxygen Concentrators and Supplies: Supplies oxygen therapy equipment and related supplies for respiratory conditions. Market share data is not precise, but it is a key growth product for the company. Competitors include Lincare, Apria Healthcare (Owens & Minor), and national and regional DME providers.
- Mobility Equipment (Wheelchairs, Scooters): Supplies a wide range of manual and power wheelchairs, mobility scooters, and accessories. Market share in this segment is fragmented among many regional and national suppliers. Competitors include Numotion, National Seating & Mobility, and local DME providers.
Market Dynamics
Industry Overview
The DME market is experiencing growth driven by an aging population, rising prevalence of chronic diseases, and increasing demand for home-based healthcare solutions. The industry is consolidating, with larger players acquiring smaller providers.
Positioning
AdaptHealth Corp. is positioned as a leading provider of DME and related services, with a focus on respiratory, sleep, and mobility solutions. Its competitive advantages include its scale, geographic reach, and relationships with healthcare providers.
Total Addressable Market (TAM)
The global durable medical equipment market is expected to reach approximately $280 billion by 2028. AdaptHealth is well-positioned to capture a portion of this TAM through organic growth and acquisitions.
Upturn SWOT Analysis
Strengths
- Large scale and market presence
- Strong relationships with healthcare providers
- Diversified product and service offerings
- Proven track record of acquisitions
Weaknesses
- High debt levels
- Dependence on reimbursement rates
- Integration risks associated with acquisitions
- Exposure to regulatory changes
Opportunities
- Further consolidation of the DME market
- Expansion into new geographic markets
- Development of new products and services
- Increased adoption of telehealth and remote patient monitoring
Threats
- Changes in reimbursement policies
- Increased competition
- Economic downturns
- Product liability risks
Competitors and Market Share
Key Competitors
- RESM
- OMC
- ITGR
Competitive Landscape
AdaptHealth competes on scale, geographic reach, and product offerings. Its advantages include its established relationships with healthcare providers and its ability to integrate acquisitions. Its disadvantages include its high debt levels and exposure to reimbursement pressures.
Major Acquisitions
AeroCare Holdings
- Year: 2021
- Acquisition Price (USD millions): 2000
- Strategic Rationale: Expanded AdaptHealth's geographic footprint and strengthened its position in the respiratory and sleep therapy markets.
Growth Trajectory and Initiatives
Historical Growth: AdaptHealth Corp. has experienced rapid growth through acquisitions and organic expansion. The company has successfully integrated numerous acquisitions and expanded its product and service offerings.
Future Projections: Analysts project continued revenue growth driven by industry trends and the company's acquisition strategy. Profitability is expected to improve as integration costs subside and synergies are realized.
Recent Initiatives: Recent strategic initiatives include focusing on organic growth, improving operational efficiencies, and investing in technology to enhance patient care.
Summary
Adapthealth is a large player in the DME market with significant growth potential, driven by industry trends and acquisitions. While its revenue is strong, its profitability is affected by high debt levels and acquisition costs. The company needs to focus on integrating acquisitions, reducing debt, and improving operational efficiency to achieve sustainable profitability. The company should watch out for reimbursement changes and competition from other large and regional DME suppliers.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Investor Presentations
- Analyst Reports
- Industry Research Reports
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market data and projections are subject to change. Investing involves risk; past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Adapthealth Corp
Exchange NASDAQ | Headquaters Plymouth Meeting, PA, United States | ||
IPO Launch date 2018-05-24 | CEO & Director Ms. Suzanne M. Foster M.P.H. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 10500 | Website https://adapthealth.com |
Full time employees 10500 | Website https://adapthealth.com |
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.